Fintel reports that on October 9, 2025, Stifel maintained coverage of Medtronic (NYSE:MDT) with a Hold recommendation.
Analyst Price Forecast Suggests 4.22% Upside
As of September 30, 2025, the average one-year price target for Medtronic is $100.56/share. The forecasts range from a low of $82.82 to a high of $118.07. The average price target represents an increase of 4.22% from its latest reported closing price of $96.48 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Medtronic is 33,717MM, a decrease of 1.41%. The projected annual non-GAAP EPS is 6.18, a decrease of 3.15% from the prior forecast.
What is the Fund Sentiment?
There are 3,399 funds or institutions reporting positions in Medtronic. This is an decrease of 17 owner(s) or 0.50% in the last quarter. Average portfolio weight of all funds dedicated to MDT is 0.49%, an increase of 5.56%. Total shares owned by institutions increased in the last three months by 0.63% to 1,294,669K shares. 
The put/call ratio of MDT is 0.61, indicating a bullish outlook.
What are Other Shareholders Doing?
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 41,239K shares representing 3.22% ownership of the company. In its prior filing, the firm reported owning 40,532K shares , representing an increase of 1.71%. The firm decreased its portfolio allocation in MDT by 11.94% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 36,406K shares representing 2.84% ownership of the company. In its prior filing, the firm reported owning 35,630K shares , representing an increase of 2.13%. The firm decreased its portfolio allocation in MDT by 11.94% over the last quarter.
Capital Research Global Investors holds 36,359K shares representing 2.83% ownership of the company. In its prior filing, the firm reported owning 41,568K shares , representing a decrease of 14.32%. The firm decreased its portfolio allocation in MDT by 21.87% over the last quarter.
Jpmorgan Chase holds 35,063K shares representing 2.73% ownership of the company. In its prior filing, the firm reported owning 37,627K shares , representing a decrease of 7.31%. The firm decreased its portfolio allocation in MDT by 19.04% over the last quarter.
Geode Capital Management holds 28,227K shares representing 2.20% ownership of the company. In its prior filing, the firm reported owning 27,916K shares , representing an increase of 1.10%. The firm decreased its portfolio allocation in MDT by 12.66% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
